MAR 26, 2019 10:00 AM PDT

TSH Receptor Antibodies: Nomenclature, Functionality and Assay Comparison

Sponsored by: Quidel
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Professor of Medicine and Endocrinology / Metabolism Johannes Gutenberg University Medical Center Mainz, Germany
    Biography
      George Jean Kahaly, M.D., Ph.D. currently holds the rank of Professor of Medicine and Endocrinology / Metabolism and is chief of the endocrine outpatient clinic at the Gutenberg University Medical Center, Mainz, Germany.

      Dr. Kahaly directs the Endocrine Research Laboratory, and has authored more than 160 original papers, covering both clinical and experimental aspects of endocrine autoimmunity, immunogenetics of thyroid and polyglandular autoimmunity, as well as cardiovascular involvement of metabolic disorders. He organized and co-chaired numerous international scientific meetings dealing with molecular and endocrine autoimmunity.

      Dr. Kahaly is currently Treasurer, main Officer, and member of the Executive Board of the European Thyroid Association (ETA). He also is member of the Finance and Audit Committee of the American Thyroid Association (ATA). In the years 2000-2006, Dr. Kahaly has been active member of the Membership and Publication Committees of the ATA. Furthermore, he is an active member of the American and European Endocrine Societies. Dr. Kahaly is currently the Treasurer and main Officer of the "European Group of Graves' Orbitopathy" (EUGOGO), official subgroup of the ETA. In 2005, he was elected member of the Executive Committee of the German Thyroid Section of the German Endocrine Society.

      Dr. Kahaly serves on the Editorial Board of the journal THYROID, the official journal of the ATA as well as on the Editorial Board of the Journal of Clinical Endocrinology & Metabolism (JCEM), official Organ of the American Endocrine Society.

    Abstract
    DATE:  March 26, 2019
    TIME:   10:00am PDT, 1:00pm EDT
     
    Despite being the most common autoimmune disorder in the United States, knowledge surrounding thyroid disorders has not received the attention it deserves.  This is unfortunate because of the diseases associated with the thyroid are completely manageable and in some cases curable. This includes the most common thyroid disorder, Grave’s Disease (GD). Additionally, many diagnoses based solely on the symptoms of thyroid disorders are performed by inadequately trained and/or experienced non-endocrine specialties. This allows for the disease to progress undetected or be improperly treated.  Proper education regarding assay testing modalities is needed for healthcare providers in order to provide better patient care.  There is a need for increased knowledge and recognition of thyroid symptoms and behaviors, and greater clinical practitioner confidence in the ability to uncover the origin of patient symptoms via proper diagnostic techniques and methodologies.
     
    This activity is designed for Clinical Laboratorians and other Healthcare Professionals interested in the management of patients with thyroid disease.  Academic content will focus on the role(s) of TSH Receptor Antibodies in Thyroid Disease, differential diagnostic modalities with attention being paid to clinical validity, as well as the diagnostic and disease management versatility of bioassays versus binding assays. Recent updates to the American Thyroid Association (ATA) guidelines will also be discussed.
     
    Learning Objectives:
    • Discuss the new American Thyroid Association (ATA) guidelines for the diagnostic testing of thyrotoxicosis.
    • Distinguish between the physiological mechanisms of thyroid stimulating and thyroid blocking immunoglobulins.
    • Describe the differences between TSH Receptor Antibody Binding Assays versus Cell-based Bioassays.

     

    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    JUL 22, 2020 10:00 AM PDT
    C.E. CREDITS
    JUL 22, 2020 10:00 AM PDT
    DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    JUN 23, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    Loading Comments...
    Show Resources
    Attendees
    • See more